Prolonged elevation of blood glucose, as well as related adverse metabolic features such as dyslipidemia and chronic inflammation, lead ultimately to a range of debilitating health issues such as, cardiovascular disease, peripheral neuropathy, diabetic ketoacidosis, diabetic retinopathy, and diabetic nephropathy
observed that weight loss and significant increases in SHBG occurred in both groups [59]
Retatrutide itself does not cause muscle loss
Our experience shows the typical timeline for noticeable effects ranges from 3 to 8 weeks , with the most significant changes often appearing after the first month
It may be reasonable to focus on whether the combination of GLP-1RAs and SGLT2is, which are expected to have complementary effects based on large-scale clinical trial results, can further reduce cardiovascular and renal events in patients with diabetes